MarketCap
Facebook
X
TelegramAnnual report 2025
added 10-14-2025
PetMed Express Interest Expense 2011-2025 | PETS
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense PetMed Express
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 758 K | 1.38 M | 944 K | 1.03 M | 1.32 M | 1.17 M | 1.08 M | 995 K | 300 K | 63 K | 1 K | -4 K | -5 K | 61 K | -128 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.38 M | -128 K | 597 K |
Quarterly Interest Expense PetMed Express
| 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 180 K | 186 K | 231 K | - | 293 K | 254 K | 506 K | - | 259 K | 261 K | 459 K | - | 287 K | 741 K | 454 K | - | 345 K | 345 K | 338 K | 255 K | 301 K | 301 K | 304 K | 257 K | 255 K | 255 K | 255 K | - | 265 K | 249 K | 241 K | - | 130 K | 206 K | 76 K | - | -4 K | -12 K | -8 K | - | -4 K | 3 K | 7 K | - | -3 K | -5 K | -1 K | - | -3 K | - | - | - | -1 K | 62 K | 63 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 741 K | -12 K | 204 K |
Interest Expense of other stocks in the Pharmaceutical retailers industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Greenlane Holdings
GNLN
|
2.45 M | $ 2.99 | -3.24 % | $ 22.5 M |  USA |
 |
BOQI International Medical
BIMI
|
170 K | - | 6.33 % | $ 5.86 M |  China |
 |
Trxade Group
MEDS
|
1.2 M | - | 4.55 % | $ 5.8 M | USA |
 |
LifeMD
LFMD
|
2.6 M | $ 3.45 | -4.43 % | $ 117 M | USA |
 |
Rite Aid Corporation
RAD
|
224 M | - | - | $ 35.5 M | USA |
 |
111
YI
|
-595 K | $ 3.7 | -4.15 % | $ 636 M | China |
 |
Walgreens Boots Alliance
WBA
|
482 M | - | - | $ 10.3 B | USA |